Needham & Company LLC restated their buy rating on shares of Apple (NASDAQ:AAPL – Free Report) in a report released on Monday,Benzinga reports. They currently have a $225.00 price target on the ...

Needham upgraded Boston Scientific (BSX) to Buy from Hold with a $113 price target Needham’s latest electrophysiologist survey shows the ...

Aurora Innovation (NASDAQ:AUR) broke higher in early trading on Tuesday after Needham initiated coverage with a Buy rating on the autonomous driving tech stock. Analyst Chris Pierce said Aurora ...

Fintel reports that on April 15, 2025, Needham upgraded their outlook for Neurocrine Biosciences (NasdaqGS:NBIX) from Hold to ...

Investing.com -- Needham&Company analysts remain positive on Lululemon (NASDAQ:LULU) ahead of its fourth-quarter earnings report, set for release after the market close on Thursday. The firm ...

Needham & Company LLC reaffirmed their buy rating on shares of Molson Coors Beverage (NYSE:TAP – Free Report) in a research report sent to investors on Monday,Benzinga reports. They currently ...

Needham analyst Ami Fadia upgraded Neurocrine (NBIX) to Buy from Hold with a $138 price target The firm cites its positive physician survey on ...

Recent acquisitions are also seen as adding to Boston Scientific’s growth story. Bolt Medical’s new device for treating ...